Auransa
Auransa is a clinical stage drug development company who aims to invent high value, novel drugs for hard-to-treat diseases like cancer, auto-immune and neurological disorders using its proprietary AI platform and drug discovery expertise. The company's platform is used to understand biology of diseases at subtype level resolution, enabling it to predict compounds and targets of novel pharmacology for responder patient population. Current internal drug pipeline includes a first-in-class investigational new drug for cancer in clinical trials. Auransa has partnership with companies and institutions in the biopharma industry.
Domain
auransa.com
Country
United StatesIndustry
Artificial Intelligence (AI)Employees
11-50
Last Funding
$15.7M
Founded
2013
Tech Stack (9 technologies)
Frequently Asked Questions
What technologies does Auransa use?+
Auransa uses 9 technologies including Squarespace, Squarespace Commerce, core-js.
What industry is Auransa in?+
Auransa operates in the Artificial Intelligence (AI) industry.
Where is Auransa based?+
Auransa is headquartered in United States.
Explore More
Need this data at scale?
Get ready-to-use datasets: companies, technologies, and tech adoption signals across 3M+ websites.
Browse DatasetsData last updated: June 2026